Natco Pharma launches FDC Trifluridine & Tipiracil first time in India

In India, approximately 1,25,000 new cases of the cancers are reported every year.

121
Medicine tablets
Picture: Unsplash

Last Updated on November 19, 2021 by The Health Master

Natco Pharma Limited has launched a novel fixed-dose combination (FDC) of trifluridine and tipiracil for the first-time in India under the brand name Tipanat as a pack of 20 tablets in a bottle.

Tipanat is a novel antineoplastic nucleoside analog indicated for the treatment of advanced colorectal and gastric cancer.

In India, approximately 1,25,000 new cases of the cancers are reported every year.

Tipanat is of high importance in not only extending the survival but also in preserving the quality of life in the late lines of treatment which is currently an unmet medical need. Natco has offered Tipanat at an affordable price.

Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad, which makes finished dosage formulations and active pharmaceutical ingredients. It is the market leader in branded oncology medicines in India, and among the country’s top three producers of hepatitis C drugs.

Notifications: New Drugs, FDC, Clinical Trial

Other details about New Drugs, FDCs, Clinical trial

MSN Labs launches Vigabatrin Powder for the treatment of Epilepsy

A portable Hydrogen inhaler launched: Dual-use technology

Lupin launches generic Fenofibrate capsules for this ailment

Sun Pharma launches acne treatment cream

Dr Reddy’s Labs launches generic Ephedrine Sulfate injection

Sun Pharma launches drug to treat Plaque Psoriasis in Canada

USFDA promises quick review of Pfizer booster vaccine for all adults

Cipla launches portable Spirometer for early diagnosis for COPD

MSN Labs launches Vigabatrin Powder for the treatment of Epilepsy

Aleor Derma gets USFDA nod for Antibacterial Cream: Alembic

No retention or renewal fees after one time registration of ASU products

International Conference on National Education Policy will be held at …

IPC adds new impurities and Reference Standards: Download the list

Drug alert: 36 out of 1061 samples declared as NSQ in October 2021

Latest Circulars by the Govt of India, Dept of Pharmaceuticals, Health…

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news

Enter your email address:

Delivered by FeedBurner